Leukemia Posts - Page 35 of 71 on Medivizor
Navigation Menu

Leukemia Posts on Medivizor

Searching for patients to test venetoclax with azacitidine treatment for acute myeloid leukemia

Posted by on Jan 27, 2019 in Leukemia | 0 comments

In a nutshell This trial is comparing the safety and effectiveness of venetoclax (Venclexta) and azacitidine (Vidaza) with azacitidine alone in patients with acute myeloid leukemia (AML). The main outcome to be measured will be overall survival. Complete remission (no signs of cancer after treatment) will also be measured. The details Acute...

Read More

ASCO’s National Cancer Opinion Survey Results

ASCO’s National Cancer Opinion Survey Results

Posted by on Jan 24, 2019 in Blog, Breast cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer |

During July and early August of  2018, the Harris Poll in association with the American Society of Clinical Oncologists (ASCO’s) conducted a poll of 4,887 U.S. adults, 1001 of these have or had cancer. This second annual National Cancer Opinion Survey explored a wide range of topics. The findings clearly describe disparities in the care patients with...

Read More

Is reducing the dose of imatinib effective in the treatment of chronic myeloid leukemia?

Is reducing the dose of imatinib effective in the treatment of chronic myeloid leukemia?

Posted by on Jan 20, 2019 in Leukemia | 0 comments

In a nutshell This study looked at the effectiveness of reducing the dose of imatinib (Gleevec) in the treatment of chronic myeloid leukemia (CML). Researchers found that a lower dose of imatinib can achieve the same result as a high dose in most patients. Some background Chronic myeloid leukemia (CML) is a cancer of the bone marrow. This leads to...

Read More

Can molecular monitoring help treatment and outcomes in patients with chronic myeloid leukemia?

Can molecular monitoring help treatment and outcomes in patients with chronic myeloid leukemia?

Posted by on Jan 12, 2019 in Leukemia | 0 comments

In a nutshell This study looked at the use of molecular monitoring to assess outcomes in patients with chronic myeloid leukemia. Researchers found that molecular monitoring at 3 and 12 months is beneficial to these patients. Some background Chronic myeloid leukemia (CML) is a cancer of the bone marrow. This leads to an abnormal immune system and...

Read More

Evaluating ibrutinib and obinutuzumab combination for the treatment of chronic lymphocytic leukemia

Evaluating ibrutinib and obinutuzumab combination for the treatment of chronic lymphocytic leukemia

Posted by on Jan 10, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the effectiveness of ibrutinib and obinutuzumab combination in patients with chronic lymphocytic leukemia. This study concluded that this combination is safe and highly effective as a treatment for these patients. Some background Obinutuzumab (Gazyva) and ibrutinib (Imbruvica)...

Read More

Venetoclax-rituximab combination improves survival in patients with unresponsive and relapsed chronic lymphocytic leukemia

Posted by on Jan 5, 2019 in Leukemia | 0 comments

In a nutshell This study looked at the effectiveness of venetoclax-rituximab (Venclexta–Rituxan) in patients with unresponsive or relapsed chronic lymphocytic leukemia (CLL). Researchers found that this treatment improved survival in patients with CLL. Some background Chronic lymphocytic leukemia is a cancer of the bone marrow. This can...

Read More

Using steroid medication to prevent stem cell transplant complications in patients with leukemia

Using steroid medication to prevent stem cell transplant complications in patients with leukemia

Posted by on Jan 5, 2019 in Leukemia | 0 comments

In a nutshell This study looked at the effects of using steroid medication to prevent complications after stem cell transplant and improve survival in patients with leukemia. Researchers found that low-dose steroids improved outcomes in these patients. Some background Leukemia is a cancer of the blood-forming tissues such as the bone...

Read More